# FDA 483 - Allergan Sales, LLC - July 09, 2010

Source: https://www.keypedia.com/records/483/allergan-sales-llc/dc2754a0-383b-4aca-b94a-0cc7b5d6a4cb

> FDA 483 for Allergan Sales, LLC on July 09, 2010. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Allergan Sales, LLC
- Inspection Date: 2010-07-09
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Allergan Inc. in Irvine, CA, from July 6-9, 2010, identified three observations. The firm failed to timely report serious and unexpected adverse drug experiences and did not submit annual periodic adverse drug experience reports or other annual reports within the required timeframes.

## Related Documents

- [483 - 2025-11-07](https://www.keypedia.com/records/483/allergan-sales-llc/12dec849-c2f0-4857-995e-202ccb5ee45b)
- [483 - 2025-11-07](https://www.keypedia.com/records/483/allergan-sales-llc/22954531-e534-441b-863f-bbedcbf15b17)

## Related Officers

- [Investigator](https://www.keypedia.com/people/binh-t-nguyen/14ca5620-1f92-4f5d-8663-3b63814aca26)

Company: https://www.keypedia.com/companies/allergan-sales-llc/1c953156-6298-4351-8d2d-bc0fa979d4eb

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6